Bioventix* (BVXP): FY 2017 results – a year of transition ahead (CORP) | Acal (ACL): Strong H1 puts positive pressure on consensus (BUY) | Omega Diagnostics* (ODX): New supply agreement in US for FoodPrint (CORP)
16 Oct 2017
Morning Note
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
Bioventix Plc (BVXP:LON), 4,600 | discoverIE Group PLC (DSCV:LON), 670 | Cambridge Nutritional Sciences PLC (CNSL:LON), 3.2
- Published:
16 Oct 2017 -
Author:
Guy Hewett | Mark Brewer | Cavendish Research -
Pages:
5
Bioventix* (BVXP): FY 2017 results – a year of transition ahead (CORP) | Acal (ACL): Strong H1 puts positive pressure on consensus (BUY) | Omega Diagnostics* (ODX): New supply agreement in US for FoodPrint (CORP)